Skip to content
Screener

Dermata Therapeutics, Inc. DRMA Q3 2025 earnings

Reported November 14, 2025 · Before market open

EPS-$1.65Miss by $0.06
EPS estimate-$1.59

Next report

Nov 18, 2026 (in 3 months)
Revenue estimate$25.0K
EPS estimate-$0.55

FAQ

When did Dermata Therapeutics, Inc. report Q3 2025 earnings?
Dermata Therapeutics, Inc. (DRMA) reported Q3 2025 earnings on November 14, 2025 before market open.
What were Dermata Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Dermata Therapeutics, Inc. reported eps of $-1.65 for Q3 2025.
Did Dermata Therapeutics, Inc. beat estimates in Q3 2025?
EPS missed the consensus estimate of $-1.59 by $0.06.
How did Dermata Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 19.1% from $-2.04.
Where can I find Dermata Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-023419) and the 10-Q periodic report (0001493152-25-023474) directly on SEC EDGAR. The filing index links above go to sec.gov.